435 related articles for article (PubMed ID: 30098594)
21. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
22. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
[TBL] [Abstract][Full Text] [Related]
23. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Kuerten S; Schickel A; Kerkloh C; Recks MS; Addicks K; Ruddle NH; Lehmann PV
Acta Neuropathol; 2012 Dec; 124(6):861-73. PubMed ID: 22842876
[TBL] [Abstract][Full Text] [Related]
24. The enteric nervous system is a potential autoimmune target in multiple sclerosis.
Wunsch M; Jabari S; Voussen B; Enders M; Srinivasan S; Cossais F; Wedel T; Boettner M; Schwarz A; Weyer L; Göcer O; Schroeter M; Maeurer M; Woenckhaus M; Pollok K; Radbruch H; Klotz L; Scholz CJ; Nickel J; Friebe A; Addicks K; Ergün S; Lehmann PV; Kuerten S
Acta Neuropathol; 2017 Aug; 134(2):281-295. PubMed ID: 28620692
[TBL] [Abstract][Full Text] [Related]
25. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis.
Myers KJ; Sprent J; Dougherty JP; Ron Y
J Neuroimmunol; 1992 Nov; 41(1):1-8. PubMed ID: 1281165
[TBL] [Abstract][Full Text] [Related]
26. Anti-CD52 antibody treatment in murine experimental autoimmune encephalomyelitis induces dynamic and differential modulation of innate immune cells in peripheral immune and central nervous systems.
Barbour M; Wood R; Harte T; Bushell TJ; Jiang HR
Immunology; 2022 Mar; 165(3):312-327. PubMed ID: 34826154
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
28. CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis.
Bogie JF; Grajchen E; Wouters E; Broux B; Stinissen P; Van Wijmeersch B; Hendriks JJ
Ther Adv Chronic Dis; 2020; 11():2040622320947378. PubMed ID: 32913622
[TBL] [Abstract][Full Text] [Related]
29. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
[TBL] [Abstract][Full Text] [Related]
30. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
31. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
Batoulis H; Wunsch M; Birkenheier J; Rottlaender A; Gorboulev V; Kuerten S
Clin Immunol; 2015 May; 158(1):47-58. PubMed ID: 25796192
[TBL] [Abstract][Full Text] [Related]
33. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Xie C; Ciric B; Yu S; Zhang GX; Rostami A
J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
[TBL] [Abstract][Full Text] [Related]
34. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
35. Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time: increased calpain activity begins with onset of disease.
Schaecher K; Rocchini A; Dinkins J; Matzelle DD; Banik NL
J Neuroimmunol; 2002 Aug; 129(1-2):1-9. PubMed ID: 12161014
[TBL] [Abstract][Full Text] [Related]
36. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
37. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
38. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.
Haile Y; Carmine-Simmen K; Olechowski C; Kerr B; Bleackley RC; Giuliani F
J Neuroinflammation; 2015 Sep; 12():157. PubMed ID: 26337722
[TBL] [Abstract][Full Text] [Related]
39. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
Breuer J; Korpos E; Hannocks MJ; Schneider-Hohendorf T; Song J; Zondler L; Herich S; Flanagan K; Korn T; Zarbock A; Kuhlmann T; Sorokin L; Wiendl H; Schwab N
J Neuroinflammation; 2018 Aug; 15(1):236. PubMed ID: 30134924
[TBL] [Abstract][Full Text] [Related]
40. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.
Kuerten S; Pauly R; Rottlaender A; Rodi M; Gruppe TL; Addicks K; Tary-Lehmann M; Lehmann PV
Clin Immunol; 2011 Jul; 140(1):54-62. PubMed ID: 21489887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
